Tech Company Financing Transactions
Phenomix Funding Round
On 10/14/2003, Phenomix raised $35.5 million in Series A funding from Alta Partners, Sofinnova Ventures and Bay City Capital.
Transaction Overview
Company Name
Announced On
10/14/2003
Transaction Type
Venture Equity
Amount
$35,500,000
Round
Series A
Investors
Alta Partners (Lead Investor) (Daniel Janney)
Sofinnova Ventures (Lead Investor) (James Healy)
Proceeds Purpose
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
5930 Cornerstone Court West 230
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Phenomix is a drug discovery and development company building a therapeutic portfolio for treatment of immune disease and metabolic syndrome.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Laura Shawver
Chief Medical Officer
Hans-Peter Guler
Vice President
Angela Birchler
Vice President
Marie O'Farrell
VP - Finance
Brian Baker
Browse more venture capital transactions:
Prev: 10/14/2003: CoTherix venture capital transaction
Next: 10/15/2003: Comverge venture capital transaction
Share this article
Where The Data Comes From
We do our best to document tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs